Company Filing History:
Years Active: 2020-2025
Title: Isabel Kurth: Innovator in Cancer Treatment
Introduction
Isabel Kurth is a prominent inventor based in New York, NY (US), known for her significant contributions to cancer treatment through innovative antibody technologies. With a total of 4 patents, she has made strides in the field of biotechnology, particularly in the development of high-affinity anti-MERTK antibodies.
Latest Patents
Her latest patents include groundbreaking work on high-affinity anti-MERTK antibodies and their uses. The present disclosure provides antibodies that specifically bind to Mer Tyrosine Kinase (MERTK) and compositions comprising such antibodies. Additionally, it details antibody-drug conjugates that combine anti-MERTK antibodies with cytotoxic agents, offering new methods for treating cancer. These methods involve administering an anti-MERTK antibody or an antibody-drug conjugate to human subjects in need of treatment.
Career Highlights
Isabel has worked with notable companies in the biotechnology sector, including Inspirna, Inc. and Rgenix, Inc. Her work has been pivotal in advancing cancer therapies, showcasing her dedication to improving patient outcomes through innovative research.
Collaborations
Isabel has collaborated with esteemed colleagues such as Masoud Tavazoie and Foster Casimir Gonsalves, further enhancing her contributions to the field of cancer treatment.
Conclusion
Isabel Kurth's innovative work in developing anti-MERTK antibodies and cancer treatment methods highlights her as a leading figure in biotechnology. Her patents and collaborations reflect her commitment to advancing medical science and improving therapeutic options for cancer patients.